Akebia Therapeutics Inc (AKBA)
1.37
+0.07
(+5.38%)
USD |
NASDAQ |
May 03, 16:00
1.42
+0.05
(+3.65%)
After-Hours: 20:00
Akebia Therapeutics 1 Year Total Returns (Daily): 55.70% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 55.70% |
| May 02, 2024 | 47.04% |
| May 01, 2024 | 42.07% |
| April 30, 2024 | 38.69% |
| April 29, 2024 | 45.29% |
| April 26, 2024 | 68.98% |
| April 25, 2024 | 86.17% |
| April 24, 2024 | 104.3% |
| April 23, 2024 | 107.5% |
| April 22, 2024 | 106.0% |
| April 19, 2024 | 88.08% |
| April 18, 2024 | 103.8% |
| April 17, 2024 | 113.8% |
| April 16, 2024 | 122.9% |
| April 15, 2024 | 121.3% |
| April 12, 2024 | 134.5% |
| April 11, 2024 | 136.1% |
| April 10, 2024 | 174.3% |
| April 09, 2024 | 185.2% |
| April 08, 2024 | 183.3% |
| April 05, 2024 | 194.7% |
| April 04, 2024 | 180.1% |
| April 03, 2024 | 157.7% |
| April 02, 2024 | 181.9% |
| April 01, 2024 | 190.9% |
| Date | Value |
|---|---|
| March 28, 2024 | 205.4% |
| March 27, 2024 | 241.3% |
| March 26, 2024 | 213.1% |
| March 25, 2024 | 246.0% |
| March 22, 2024 | 225.1% |
| March 21, 2024 | 191.4% |
| March 20, 2024 | 186.6% |
| March 19, 2024 | 188.3% |
| March 18, 2024 | 197.7% |
| March 15, 2024 | 153.2% |
| March 14, 2024 | 100.5% |
| March 13, 2024 | 86.68% |
| March 12, 2024 | 77.72% |
| March 11, 2024 | 80.23% |
| March 08, 2024 | 42.72% |
| March 07, 2024 | 54.40% |
| March 06, 2024 | 58.17% |
| March 05, 2024 | 65.80% |
| March 04, 2024 | 67.88% |
| March 01, 2024 | 86.91% |
| February 29, 2024 | 87.49% |
| February 28, 2024 | 82.75% |
| February 27, 2024 | 101.1% |
| February 26, 2024 | 82.96% |
| February 23, 2024 | 82.43% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.80%
Minimum
Nov 02 2022
379.8%
Maximum
Aug 01 2023
14.95%
Average
-36.51%
Median
Jan 21 2022
1 Year Total Returns (Daily) Benchmarks
| Ocugen Inc | 90.49% |
| Aquestive Therapeutics Inc | 109.5% |
| SELLAS Life Sciences Group Inc | -11.92% |
| Protagonist Therapeutics Inc | 6.71% |
| Stoke Therapeutics Inc | 26.66% |